Detalhe da pesquisa
1.
Role of p53 in transcriptional repression of SVCT2.
Mol Biol Rep
; 48(2): 1651-1658, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580460
2.
Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.
Biochem Biophys Res Commun
; 527(1): 305-310, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446385
3.
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells.
Invest New Drugs
; 38(6): 1696-1706, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462369
4.
Targeting ß-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.
Br J Cancer
; 120(9): 941-951, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944457
5.
Cellular inhibitor of apoptosis protein 1 (cIAP1) stability contributes to YM155 resistance in human gastric cancer cells.
J Biol Chem
; 290(16): 9974-85, 2015 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25635055
6.
SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.
Tumour Biol
; 37(4): 4323-30, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26493999
7.
NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotype.
Apoptosis
; 19(5): 895-904, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652480
8.
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants.
Invest New Drugs
; 32(3): 389-99, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173966
9.
The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy.
Cancer Immunol Res
; 12(4): 491-507, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289363
10.
Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).
J Biol Chem
; 287(28): 24017-25, 2012 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22628551
11.
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
Cell Death Differ
; 30(12): 2491-2507, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37926711
12.
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer.
Anticancer Res
; 42(4): 1813-1819, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35346999
13.
Foxp3 expression in p53-dependent DNA damage responses.
J Biol Chem
; 285(11): 7995-8002, 2010 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20075077
14.
Mutation SVCT2 promotes cell proliferation, invasion and migration in colorectal cancer.
J Cancer
; 12(18): 5385-5393, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405001
15.
Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells.
Redox Biol
; 37: 101716, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961441
16.
Sulindac induces apoptotic cell death in susceptible human breast cancer cells through, at least in part, inhibition of IKKbeta.
Apoptosis
; 14(7): 913-22, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19526344
17.
Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells.
Int J Oncol
; 32(2): 435-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18202766
18.
Vitamin C inhibits p53-induced replicative senescence through suppression of ROS production and p38 MAPK activity.
Int J Mol Med
; 22(5): 651-5, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18949386
19.
Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.
Toxicol In Vitro
; 46: 229-236, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947240
20.
Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.
Toxicol Lett
; 258: 126-133, 2016 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27339904